AngioDynamics Earns 510(k) Clearance and CE Mark for Implantable Port

New York-based AngioDynamics said it has received 510(k) clearance from the FDA and a CE mark in Europe for its SmartPort+ implantable port.

The subcutaneous port provides long-term access for blood specimen withdrawal and the administration of fluids to patients.

The company said it will immediately launch the product in the U.S. and Europe.